|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/713 | (2006.01) |
| A61P 31/20 | (2006.01) | ||
| A61K 39/42 | (2006.01) |
| (11) | Number of the document | 3897672 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19842679.3 |
| Date of filing the European patent application | 2019-12-19 | |
| (97) | Date of publication of the European application | 2021-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation | 2023-11-10 |
| (86) | Number | PCT/US2019/067643 |
| Date | 2019-12-19 |
| (87) | Number | WO 2020/132346 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201862782896 P | 2018-12-20 | US |
| (72) |
BAKARDJIEV, Anna , US
PANG, Phillip S. , US
CORTI, Davide , CH
|
| (73) |
Vir Biotechnology, Inc. ,
1800 Owens Street
Suite 900, San Francisco, CA 94158,
US
Humabs Biomed SA , Via dei Gaggini, 3, 6500 Bellinzona, CH |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuota HBV terapija |
| COMBINATION HBV THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-12-02 | 7 | 162.00 EUR |
| 2026-12-19 |